title: [Leishmania epidemiology, diagnosis, chemotherapy and vaccination approaches in the international network of Pasteur Institutes].
abstract: Protozoan parasites of the genus Leishmania generate severe human diseases termed leishmaniases. Due to their frequency and the severity of certain clinical forms, these diseases represent a major public health problem and limit the economic growth in various developing countries. The presence of Pasteur Institutes in countries with endemic leishmaniasis has provided important incentives to develop a strong public health agenda in the Pasteur scientific community with respect to this important disease. A concerted effort is now coordinated through the recently created LeishRIIP platform (www.leishriip.org), which aims to identify synergies and complementary expertise between the eleven members of the international network of Pasteur Institutes working on various aspects of the disease including epidemiology, diagnosis, chemotherapy and vaccination.
authors.affiliation: Laboratoire transmission, contrôle et immunobiologie des infections, LR 11-IPT-02, Institut Pasteur de Tunis, 13, place Pasteur, BP 74, 1002 Tunis, Tunisie.
authors.forename: Hechmi
authors.initials: H
authors.lastname: Louzir
authors.affiliation: Laboratoire de parasitologie-mycologie, LR 11-IPT-06 parasitoses médicales, biotechnologie et biomolécules, Institut Pasteur de Tunis, 13, place Pasteur, BP 74, 1002 Tunis, Tunisie.
authors.forename: Karim
authors.initials: K
authors.lastname: Aoun
authors.affiliation: Unité de parasitologie moléculaire et signalisation, CNRS, URA 2581, Institut Pasteur, 25, rue du Docteur Roux, 75015 Paris, France.
authors.forename: Gerald F
authors.initials: GF
authors.lastname: Späth
authors.affiliation: Laboratoire transmission, contrôle et immunobiologie des infections, LR 11-IPT-02, Institut Pasteur de Tunis, 13, place Pasteur, BP 74, 1002 Tunis, Tunisie.
authors.forename: Dhafer
authors.initials: D
authors.lastname: Laouini
authors.affiliation: Unité de parasitologie moléculaire et signalisation, CNRS, URA 2581, Institut Pasteur, 25, rue du Docteur Roux, 75015 Paris, France.
authors.forename: Eric
authors.initials: E
authors.lastname: Prina
authors.affiliation: Direction internationale, Institut Pasteur, 25, rue du Docteur Roux, 75015 Paris, France.
authors.forename: Kathleen
authors.initials: K
authors.lastname: Victoir
authors.affiliation: Laboratoire de parasitologie-mycologie, LR 11-IPT-06 parasitoses médicales, biotechnologie et biomolécules, Institut Pasteur de Tunis, 13, place Pasteur, BP 74, 1002 Tunis, Tunisie.
authors.forename: Aïda
authors.initials: A
authors.lastname: Bouratbine
mesh_terms: D000047:Academies and Institutes; D000818:Animals; D000981:Antiprotozoal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003906:Developing Countries; D004199:Disease Vectors; D019353:Endemic Diseases; D006801:Humans; D007391:International Cooperation; D007891:Leishmania / Q000276:immunology; D007896:Leishmaniasis / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D011634:Public Health; D014611:Vaccination
chemical_list: D000981:Antiprotozoal Agents